SG3 Management, LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 51 filers reported holding PLURISTEM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$21,000
-87.7%
14,200
-77.9%
0.00%
-100.0%
Q3 2021$171,000
-80.5%
64,200
-71.0%
0.01%
-83.9%
Q2 2021$878,000
+1191.2%
221,743
+1461.6%
0.03%
+1450.0%
Q1 2021$68,000
-32.0%
14,2000.0%0.00%0.0%
Q4 2020$100,00014,2000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders